Stay updated on Nivo/Ipil Immunotransplant in DLBCL Clinical Trial
Sign up to get notified when there's something new on the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page.

Latest updates to the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2 in the page footer.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded the MeSH term Malignant lymphoma, large B-cell, diffuse to the study indexing terms and included a Genetic and Rare Diseases Information Center resources entry.SummaryDifference0.2%

- Check40 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check76 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.5%

- Check83 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and the page revision now shows Revision: v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

Stay in the know with updates to Nivo/Ipil Immunotransplant in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page.